Deservedly or not, Pfizer’s vaccine is arguably the most hyped among all COVID-19 vaccines in Indonesia. And now Jakartans can get their jab after Indonesia received their first shipment of the vaccine recently — but the rollout is extremely limited at the moment.
Starting today, the Pfizer vaccine is available at four locations, namely the Cilandak District and Lebak Bulus Sub-district Puskesmas (community clinics) in South Jakarta, the Health Ministry BPSDM (training center) on Jalan Hang Jebat, Kebayoran Baru, South Jakarta, and the Judo Stadium in Kelapa Gading, East Jakarta.
To register for the Pfizer jab in Cilandak or Lebak Bulus, you can follow the links contained in the post below. Do note that the clinics are only administering 60 Pfizer jabs per day, and you are advised to follow the Instagram account for further updates or changes regarding registration.
To get your shot in Kelapa Gading, you can register via the JAKI smart city app. As for the Hang Jebat vaccination drive, you can register via Loket but do note that there is currently no option to choose which vaccine you want to receive (which is all well and good, because the best vaccine you can get is the one that is immediately available to you).
At all of these locations, the Pfizer jab is only available for those over the age of 18 and have passed the medical screening on site. Currently, the Pfizer vaccine is not meant to be administered as a third or a booster shot, and is only available to those who have not yet received their first COVID-19 vaccine dose.
Indonesia received a shipment of some 1.5 million doses of the mRNA-based vaccine on Thursday, with this particular batch purchased by the government. The country is expected to receive around 50 million doses of the Pfizer vaccine in total this year, including 4.6 million doses in the coming weeks donated by a WHO-backed initiative to distribute vaccines to developing countries.
In the early stages, the Health Ministry said the Pfizer vaccine would only be available in the Greater Jakarta Area as facilities able to handle and store the doses in the required temperatures of -60 to -90 degrees Celsius are not yet available outside of the capital.
Indonesia’s Food and Drugs Monitoring Agency (BPOM) issued its emergency use authorization for the Pfizer vaccine in mid-July, making it the second mRNA vaccine to get regulatory approval in the country after the Moderna vaccine.